Dr Anas Alawawdeh

Become a Patient

Dr Anas Alawawdeh is committed to providing his patients with comprehensive, personalised treatment. His compassionate approach to care and attention to detail reassures patients they are in the best hands.


Dr Anas Alawawdeh is a medical oncologist at Icon Cancer Centre Windsor Gardens and Icon Cancer Centre Adelaide. In 2008 he obtained his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree at the University of Jordan and subsequently undertook surgical oncology training at the King Hussein Cancer Centre in Amman, Jordan. Relocating to Australia in 2012, Dr Alawawdeh undertook postgraduate training at Lyell McEwin Hospital and completed specialist oncology training at The Queen Elizabeth Hospital, Lyell McEwin Hospital and Flinders Medical Centre.

He maintains a strong interest in clinical research and clinical trials, recently completing a gastrointestinal cancer clinical fellowship at The Queen Elizabeth Hospital. During his fellowship Dr Alawawdeh coordinated several early clinical trials of novel targeted therapies and immunotherapies in different tumour types. Dr Alawawdeh is a fellow of the Royal Australasian College of Physicians (FRACP) and a member of several leading national and international clinical cancer trials groups.

His clinical experience covers a broad range of solid tumour malignancies with special interest in gastrointestinal cancer, prostate cancer, lung cancer, breast cancer and melanoma. Dr Alawawdeh can converse in Arabic and looks forward to working with patients in their language.

Affiliations & Memberships

  • Australasian Gastro-Intestinal Cancer Trials Group (AGITG)
  • American Society of Clinical Oncology (ASCO)
  • European Society for Medical Oncology (ESMO)
  • Royal Australasian College of Physicians (RACP)

Special Interests

Dr Anas Alawawdeh accepts referrals for all cancer types, with a special clinical interest in:
  • Breast cancer
  • Clinical research
  • Gastrointestinal cancer
  • Lung cancer
  • 前列腺癌


  • Curative therapy for rectal cancer. Alawawdeh, T. Krishnan, A. Roy, C. Karapetis, R. Joshi, N. Singhal & T. Price. Expert Review of Anticancer Therapy, 2021; 21(2): 193-203.

  • A phase I study of oncolytic immunotherapy of metastatic neuroendocrine tumors using intralesional rose bengal disodium: Cohort 1 results. T. Price, G. Cehric, E. Wachter, I. Kirkwood, R. Sebbon, L. Leopardi, J. Reid, A. Alawawdeh, S.J. Neuhas & G. Maddern. Journal of Clinical Oncology, 2019; 37:15_suppl, 4102.

  • Cisplatin and Vinorelbine and Radiotherapy for local advanced non-small cell lung cancer – how good is it? R. Roberts-Thomson, A. Alawawdeh, K. Pittman, V. Broadbridge, A. Townsend, T. Price & W. Patterson. COSA, 2018.